Financials data is unavailable for this security.
View more
Year on year Evolent Health Inc had net income fall 489.86% from a loss of 19.16m to a larger loss of 113.04m despite revenues that grew 45.26% from 1.35bn to 1.96bn over the same period.
Gross margin | 18.57% |
---|---|
Net profit margin | -3.16% |
Operating margin | -2.80% |
Return on assets | -2.91% |
---|---|
Return on equity | -9.89% |
Return on investment | -3.63% |
More ▼
Cash flow in USDView more
In 2023, Evolent Health Inc did not generate a significant amount of cash. Cash Flow from Financing totalled 281.34m or 14.33% of revenues. In addition the company generated 142.58m in cash from operations while cash used for investing totalled 415.54m.
Cash flow per share | 0.1347 |
---|---|
Price/Cash flow per share | 101.49 |
Book value per share | 10.79 |
---|---|
Tangible book value per share | -5.14 |
More ▼
Balance sheet in USDView more
Current ratio | 1.08 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.4836 |
---|---|
Total debt/total capital | 0.326 |
More ▼